Pascal Deschatelets
CIK 1657720 · Chief Scientific Officer · last filed 2026-05-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
64
Lifetime Open-Market Net
-$32.32M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. (APLS) Delisted | Chief Scientific Officer | 0 | $41.03 | $0 | -$32.32M | 64 | 2026-05-14 |
Recent Filings · Page 2 of 7
64 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-14 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −2,288 | -$65.7K | EDGAR |
| 2024-05-21 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Exer (M) | +24,500 | $92.1K | EDGAR |
| 2024-05-09 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | — | -$3.00M | EDGAR |
| 2024-04-09 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | — | -$3.48M | EDGAR |
| 2024-03-11 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | — | -$4.04M | EDGAR |
| 2024-02-13 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −1,148 | -$77.8K | EDGAR |
| 2024-01-31 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −874 | -$56.1K | EDGAR |
| 2024-01-23 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −3,913 | -$254.3K | EDGAR |
| 2024-01-17 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | +5,111 | -$109.0K | EDGAR |
| 2023-11-15 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Exer (M) | +45,000 | $169.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.